
Group 1 - Tango Therapeutics, Inc. (TNGX) shares have increased by 18.7% over the past four weeks, closing at $6.46, with a mean price target of $10.43 indicating a potential upside of 61.5% [1] - The mean estimate consists of seven short-term price targets with a standard deviation of $2.23, where the lowest estimate is $8.00 (23.8% increase) and the highest is $13.00 (101.2% increase) [2] - Analysts show strong agreement on TNGX's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for TNGX has increased by 1% due to one upward revision in earnings estimates over the last 30 days, with no negative revisions [12] - TNGX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a directional guide for price movement [14]